Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Timolol maleate gel is a non-selective beta-adrenergic receptor blocking agent used in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. When applied topically on the eye, it forms a gel in the precorneal tear film that is subsequently removed by the flow of tears. The precise mechanism of the ocular hypotensive action is not clearly established, but studies suggest it may be related to reduced aqueous formation. The placebo component indicates this is likely a clinical trial formulation where timolol maleate gel is being compared with a placebo control.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on timolol maleate gel + placebo.